Skip to content

Glimepiride

Glimepiride is a sulfonylurea that stimulates insulin release in type 2 diabetes. Hypoglycaemia is its most important immediate risk. Listed uses include type 2 diabetes mellitus.

Amaryl

Type 2 Diabetes Mellitus

1 · 2 · 4mg

Glimepiride 1mg, 2mg and 4mg tablets, used for type 2 diabetes mellitus. A sulfonylurea that prompts insulin release from pancreatic beta cells.

From$0.69/ tabletView

Key points

  • Skipped meals, alcohol, exercise changes or illness can alter low-glucose risk.
  • Kidney or liver impairment and other diabetes medicines can increase exposure or hypoglycaemia.
  • It does not treat type 1 diabetes or diabetic ketoacidosis.

Listings are for comparison only; suitability and supply depend on diabetes assessment, prescription, glucose monitoring and pharmacy checks.

Important safety checks

Review kidney and liver function, meal pattern, pregnancy, alcohol, prior hypoglycaemia and all glucose-lowering medicines. Carry and follow the agreed low-glucose plan.

When to seek urgent care

Seek urgent help for seizure, loss of consciousness, severe confusion or low glucose that does not respond to the action plan. Facial swelling or breathing difficulty also needs emergency care.

Further reading